Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model

This study aims to improve how oral mucosal disorders-such as oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, herpes viral infection and oral candidiasis-are treated in dental settings. A pharmacist will work with dentists to review prescriptions, provide feedback, counsel patients, and monitor medication safety. Dental clinics will be assigned to either the pharmacist-led model or usual care. The study will evaluate whether this approach improves prescribing quality, patient adherence, symptom control, and safety. The findings may help establish a more standardized, effective way to manage these common oral conditions in routine dental practice.

Inclusion Criteria: * Adults aged 18 years and above * Diagnosed with an oral mucosal disorder (oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, Herpes viral infection or oral candidiasis) * Attending participating dental clinic sessions during the study period * Prescribed pharmacological treatment for the oral mucosal condition * Able and willing to provide written informed consent Exclusion Criteria: * Patients without a confirmed diagnosis of an oral mucosal disorder * Patients requiring immediate emergency care or hospitalization * Patients currently enrolled in another interventional clinical trial * Known hypersensitivity to commonly prescribed medications used in the study * Patients unable to comply with follow-up or study procedures